2007-02-13 01:14:30 · 3 answers · asked by the chosen one 1 in Health ➔ Diseases & Conditions ➔ Infectious Diseases
Treatment of leprosy with only one antileprosy drug will always result in development of drug resistance to that drug. Treatment with dapsone or any other antileprosy drug used as monotherapy should be considered as unethical practice.
Treatment of Leprosy: MDT (Multidrug Therapy) Regimens
Multibacillary leprosy[i] (adults)
Duration of treatment: 1 year (previously 2 years)
Rifampicin: 600mg monthly
Clofazimine: 300mg monthly and 50mg daily
Dapsone: 100mg daily
Multidrug therapy for multibacillary leprosy. MDT packs are now donated to WHO by Novartis
Paucibacillary leprosy[i] (adults)
Duration of treatment: 6 months
Rifampicin: 600mg monthly
Dapsone: 100mg daily
Multidrug therapy for paucibacillary leprosy. MDT packs are now donated to WHO by Novartis
Single lesion paucibacillary leprosy (adults)
Single dose of:
Rifampicin: 600mg
Ofloxacin: 400mg
Minocycline: 100mg
2007-02-13 01:20:16 · answer #1 · answered by iroc 7 · 2⤊ 1⤋
The extremely slow rate of growth associated with the causative agent of leprosy necessitates a multi-focal approach to antimicrobial therapy. Simply put, all of the mycobacteria grow so dang slow that conventional therapy just doesn't work.
2007-02-13 06:19:48 · answer #2 · answered by Jack D 2 · 0⤊ 1⤋
Per your e-mail request I have taken my answer off.
'-)
2007-02-13 01:18:51 · answer #3 · answered by Anonymous · 0⤊ 2⤋